Targeted integration into stem cells

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9834787
APP PUB NO 20110027235A1
SERIAL NO

12798749

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are methods and compositions for targeted integration of sequences of interest such as lineage-specific or cell fate reporter constructs or protein encoding sequences into stem cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANGAMO THERAPEUTICS INC7000 MARINA BOULEVARD BRISBANE CA 94005

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gregory, Philip D Orinda, CA 75 3383
Hockemeyer, Dirk Cambridge, US 1 38
Holmes, Michael C Oakland, US 88 3928
Jaenisch, Rudolf Cambridge, US 59 935
Soldner, Frank Cambridge, US 3 67
Urnov, Fyodor Point Richmond, US 106 5060
Yao, Shuyuan San Diego, US 2 108

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 5, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 5, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00